Inspire Receives Milestone Payment for Completion of Phase 3 Testing in Japan for Dry Eye Program...

yahoo.com     May 16, 2008            

DURHAM, N.C.----Inspire Pharmaceuticals, Inc. announced today the receipt of a $1.25 million milestone payment from its Asian dry eye partner, Santen Pharmaceutical Co., Ltd., related to the completion of Santen's Phase 3 testing of diquafosol tetrasodium, referred to as DE-089, for the treatment... [read full story]                

Full Coverage

Inspire Pharma gets $1.5M milestone payment

chron.com     May 16, 2008          

NEW YORK — Drug developer Inspire Pharmaceuticals Inc. said Friday it received a $1.3 million milestone payment for the dry eye treatment DE-089 from its Japanese partner Santen Pharmaceutical Co. Ltd. Inspire said it received the payment because Santen completed a late-stage trial of the drug,...                

comments

Inspire paid $1.25M for achieving milestone (at bizjournals.com)

yahoo.com     May 16, 2008          

has received a $1.25 million milestone payment from a Japanese drug partner, it said Friday. Durham-based Inspire (Nasdaq: ISPH) says the payment came from Santen Pharmaceutical Co., its Asian partner on the dry-eye drug diquafosol tetrasodium. Santen recently finished phase III trials on the...                

comments

Inspire Pharma gets $1.5M milestone payment (AP)

yahoo.com     May 16, 2008          

Friday May 16, 8:28 am ET Inspire Pharmacueticals gets $1.5 million milestone payment from Japanese partner NEW YORK (AP) -- Drug developer Inspire Pharmaceuticals Inc. said Friday it received a $1.3 million milestone payment for the dry eye treatment DE-089 from its Japanese partner Santen...                

comments

Inspire obtains milestone payment from Santen

pharmaceutical-business-review.com     May 17, 2008          

Inspire Pharmaceuticals has received $1.25 million milestone payment from Santen Pharmaceutical, related to the completion of Santen's Phase III testing of diquafosol tetrasodium, for the treatment of dry eye. Santen has announced that it expects to file an application by the end of June 2008 for...                

comments